De Meyts P
Unité de Biochimie, département de Chimie de l'Université catholique de Louvain.
Bull Mem Acad R Med Belg. 1994;149(3-4):181-90; discussion 190-4.
A novel mechanism of activation of the insulin and IGF-I receptors by their respective ligands is proposed, whereby the bivalent ligand bridges the two receptor alpha subunits at opposite sites in a symmetrical receptor structure. The proposed mechanism accounts for the binding stoichiometry and the phenomenon of negative cooperativity. It may play an important role in the regulation of mitogenesis.